Piper Sandler Increases Trupanion (NASDAQ:TRUP) Price Target to $57.00

Trupanion (NASDAQ:TRUP) had its target price lifted by Piper Sandler from $45.00 to $57.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage presently has a “neutral” rating on the financial services provider’s stock. Piper Sandler’s price target indicates a potential upside of 4.47% from the stock’s current price.

A number of other research firms also recently issued reports on TRUP. Bank of America raised their price objective on shares of Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a report on Friday, September 20th. Stifel Nicolaus lifted their price target on shares of Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a report on Monday, September 23rd. Northland Securities increased their price objective on Trupanion from $35.00 to $45.00 and gave the company a “market perform” rating in a report on Thursday, September 19th. Evercore ISI raised Trupanion to a “strong-buy” rating in a research report on Friday, August 9th. Finally, William Blair assumed coverage on Trupanion in a research report on Friday, July 19th. They set an “outperform” rating on the stock. Four equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, Trupanion currently has a consensus rating of “Moderate Buy” and a consensus price target of $44.67.

Trupanion Price Performance

Shares of NASDAQ TRUP opened at $54.56 on Thursday. The company has a market capitalization of $2.30 billion, a PE ratio of -170.50 and a beta of 1.73. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.42. The stock’s 50 day moving average price is $47.08 and its 200-day moving average price is $36.23. Trupanion has a twelve month low of $19.69 and a twelve month high of $57.90.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.09. The firm had revenue of $327.50 million during the quarter, compared to the consensus estimate of $321.79 million. Trupanion had a negative return on equity of 4.42% and a negative net margin of 1.08%. The business’s revenue for the quarter was up 14.6% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.10) EPS. On average, equities analysts anticipate that Trupanion will post -0.34 EPS for the current year.

Insider Activity

In related news, CFO Fawwad Qureshi sold 640 shares of the stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $43.12, for a total transaction of $27,596.80. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, CFO Fawwad Qureshi sold 640 shares of the business’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $43.12, for a total transaction of $27,596.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Margaret Tooth sold 7,500 shares of the stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total transaction of $348,600.00. Following the completion of the sale, the chief executive officer now owns 99,984 shares in the company, valued at $4,647,256.32. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 8,764 shares of company stock worth $405,238. 5.50% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Trupanion

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. GAMMA Investing LLC lifted its position in Trupanion by 70.4% during the third quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock valued at $61,000 after purchasing an additional 596 shares during the last quarter. Headlands Technologies LLC bought a new stake in shares of Trupanion during the 2nd quarter worth $162,000. Handelsbanken Fonder AB purchased a new position in Trupanion in the third quarter worth $248,000. Oppenheimer Asset Management Inc. bought a new position in Trupanion in the second quarter valued at $235,000. Finally, Bayesian Capital Management LP bought a new position in Trupanion in the first quarter valued at $253,000.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.